comparemela.com

Latest Breaking News On - Iterum therapeutics - Page 3 : comparemela.com

Critical Survey: Iterum Therapeutics (NASDAQ:ITRM) & RedHill Biopharma (NASDAQ:RDHL)

Iterum Therapeutics (NASDAQ:ITRM – Get Free Report) and RedHill Biopharma (NASDAQ:RDHL – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Analyst Ratings This is a breakdown of […]

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Resubmission of NDA On Track for Early Q2 24— Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24 Company to host conference call today at 8:30amET DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today r

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.